Stemtech Corp (STEK) Research & Development (2021 - 2023)
Stemtech (STEK) posted Research & Development of -$373302.0 for Q4 2023, down 413.38% sequentially from $119123.0 in Q3 2023, and up 6.68% YoY from -$349931.2 in Q4 2022.
Stemtech Corp (STEK) Research & Development (2021 - 2023) Analysis & Trends
Stemtech has reported Research & Development for 3 years, with the latest figure at -$373302.0 in Q4 2023.
- Quarterly Research & Development rose 6.68% year-over-year to -$373302.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$373302.0 (down 39.86% YoY) and the FY2023 annual result came in at $13800.0, changed N/A from the prior year.
- Research & Development retreated to -$373302.0 in Q4 2023 per STEK's latest filing, from $119123.0 in the prior quarter.
- Over five years, Research & Development peaked at $435579.0 in Q4 2021 and troughed at -$400018.0 in Q4 2022.
- A 3-year average of $32761.6 and a median of $93316.0 in 2021 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 29.06% in 2022, down 191.84% in 2022.
- Over 3 years, Research & Development stood at $435579.0 in 2021, then plunged by 191.84% to -$400018.0 in 2022, then increased by 6.68% to -$373302.0 in 2023.
- According to Business Quant data, Research & Development over the past three periods registered -$373302.0, $119123.0, and $177.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -373,302.00 |
| Sep 30, 2023 | 119,123.00 |
| Jun 30, 2023 | 177.00 |
| Mar 31, 2023 | 13,800.00 |
| Dec 31, 2022 | -400,018.00 |
| Sep 30, 2022 | 120,434.00 |
| Mar 31, 2022 | 140,309.00 |
| Dec 31, 2021 | 435,579.00 |
| Sep 30, 2021 | 93,316.00 |
| Jun 30, 2021 | 81,355.00 |
| Mar 31, 2021 | 129,605.00 |